SEC Form 4 · accession 0001127602-17-009676
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lucia Celona
Officer — EVP, HR & Corp Commun. Officer
Period of report
Feb 28, 2017
Accepted (ET)
Mar 2, 2017 · 4:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 28, 2017 | A | 22,567 | $0.00 | A | 22,567 | D | |
| Common StockF2 | Feb 28, 2017 | F | 650 | $43.42 | D | 21,917 | D | |
| Common Stock | Feb 28, 2017 | F | 235 | $49.56 | D | 21,682 | D | |
| Common StockF2 | Feb 28, 2017 | F | 768 | $47.76 | D | 20,914 | D | |
| Common StockF2 | Feb 28, 2017 | F | 301 | $43.42 | D | 20,613 | D | |
| Common StockF2 | Feb 28, 2017 | F | 182 | $49.56 | D | 20,431 | D | |
| Common StockF2 | Feb 28, 2017 | F | 592 | $47.76 | D | 19,839 | D | |
| Common StockF2 | Feb 28, 2017 | F | 790 | $43.42 | D | 19,049 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted stock units granted by Bioverativ Inc. ("Bioverativ") to the reporting person as a result of the conversion of existing Biogen Inc. ("Biogen") cash-settled performance units, market stock units and restricted stock units held by the reporting person prior to the Spin-Off of Bioverativ from Biogen on February 1, 2017, as set forth in an employee matters agreement entered into between Bioverativ and Biogen in connection with the Spin-Off. Restricted stock units that are unvested continue to vest on the dates of the original Biogen awards.
- F2Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.